Cargando…

MiR-205 Regulates LRRK2 Expression in Dopamine Neurons in Parkinson’s Disease through Methylation Modification

BACKGROUND: We explored the methylation modification in miR-205 promoter during the pathological changes of Parkinson’s disease (PD) and its regulation on Leucine-Rich Repeat Kinase 2 (LRRK2), clarified the important role of methylation in miR-205 promoter region in PD, explained the role of miR-205...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongwei, Li, Jie, Tao, Liang, Lv, Luting, Sun, Jinghui, Zhang, Tengteng, Wang, Huimin, Wang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529724/ https://www.ncbi.nlm.nih.gov/pubmed/36248294 http://dx.doi.org/10.18502/ijph.v51i7.10098

Ejemplares similares

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease()
por: Schlaudraff, Falk, et al.
Publicado: (2014)

MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
por: Li, Jing-Hua, et al.
Publicado: (2017)

MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities
por: Xiao, Yajuan, et al.
Publicado: (2019)

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016)

Role of LRRK2 in the regulation of dopamine receptor trafficking
por: Rassu, Mauro, et al.
Publicado: (2017)

Prognostic Significance of miR-205 in Endometrial Cancer
por: Karaayvaz, Mihriban, et al.
Publicado: (2012)

miR-205 in Breast Cancer: State of the Art
por: Plantamura, Ilaria, et al.
Publicado: (2020)

LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons
por: Skiteva, Olga, et al.
Publicado: (2022)

The Expression of miR-205 in Prostate Carcinoma and the Relationship with Prognosis in Patients
por: Guo, Zhuifeng, et al.
Publicado: (2022)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
por: Tozzi, Alessandro, et al.
Publicado: (2018)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

miR-205: A Potential Biomedicine for Cancer Therapy
por: Chauhan, Neeraj, et al.
Publicado: (2020)

Vof16-miR-205-Gnb3 axis regulates hippocampal neuron functions in cognitively impaired diabetic rats
por: Peng, Wenfang, et al.
Publicado: (2021)

MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer
por: Eyking, Annette, et al.
Publicado: (2016)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers
por: Gersel Stokholm, Morten, et al.
Publicado: (2020)

miR-205-5p inhibits homocysteine-induced pulmonary microvascular endothelium dysfunction by targeting FOXO1: miR-205-5p inhibits pulmonary microvascular endothelial dysfunction
por: Huang, Xiaobo, et al.
Publicado: (2023)

Membrane remodeling properties of the Parkinson’s disease protein LRRK2
por: Wang, Xinbo, et al.
Publicado: (2023)

LncRNA SNHG5 Promotes Proliferation of Glioma by Regulating miR-205-5p/ZEB2 Axis
por: Meng, Xiangrui, et al.
Publicado: (2019)

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1
por: Azkona, Garikoitz, et al.
Publicado: (2016)

miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT
por: Wang, Bin, et al.
Publicado: (2016)

Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis
por: He, Liuqing, et al.
Publicado: (2019)

Suppression of cell growth and invasion by miR-205 in breast cancer
por: Wu, Hailong, et al.
Publicado: (2009)

miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
por: Zhuo, Zhihong, et al.
Publicado: (2017)

miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes()
por: McKenna, Declan J., et al.
Publicado: (2014)

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands
por: Naakka, Erika, et al.
Publicado: (2022)

Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
por: Zhou, Hongxia, et al.
Publicado: (2011)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2rinugkmqn76pt9cju7qbf6e7